1. Jeremy Arceneaux

    Everist Gen. to Acquire Angiologix

    by
    Comment
    This press release was published in MarketWatch on October 31st 2011 via PR Newswire “Everist Genomics, a rapidly growing personalized medicine company developing and commercializing innovative diagnostics and prognostics, announced today that it has successfully completed acquisition of 100% of the shares of Angiologix, Inc., the developer of the AngioDefender(TM)...

Subscribe